251 related articles for article (PubMed ID: 32312953)
1. Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment.
Kant S; Kesarwani P; Prabhu A; Graham SF; Buelow KL; Nakano I; Chinnaiyan P
Cell Death Dis; 2020 Apr; 11(4):253. PubMed ID: 32312953
[TBL] [Abstract][Full Text] [Related]
2. Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
Prabhu AH; Kant S; Kesarwani P; Ahmed K; Forsyth P; Nakano I; Chinnaiyan P
Neuro Oncol; 2019 Feb; 21(3):337-347. PubMed ID: 30476237
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme.
Tamas C; Tamas F; Kovecsi A; Cehan A; Balasa A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791520
[TBL] [Abstract][Full Text] [Related]
4. Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma.
Kesarwani P; Prabhu A; Kant S; Chinnaiyan P
Cancer Immunol Immunother; 2019 Jul; 68(7):1107-1120. PubMed ID: 31119318
[TBL] [Abstract][Full Text] [Related]
5. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
[No Abstract] [Full Text] [Related]
6. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
7. Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation.
Duman C; Yaqubi K; Hoffmann A; Acikgöz AA; Korshunov A; Bendszus M; Herold-Mende C; Liu HK; Alfonso J
Cell Metab; 2019 Aug; 30(2):274-289.e5. PubMed ID: 31056285
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.
Ma Y; Temkin SM; Hawkridge AM; Guo C; Wang W; Wang XY; Fang X
Cancer Lett; 2018 Oct; 435():92-100. PubMed ID: 30102953
[TBL] [Abstract][Full Text] [Related]
9. Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma.
Kant S; Kesarwani P; Guastella AR; Kumar P; Graham SF; Buelow KL; Nakano I; Chinnaiyan P
Mol Cancer Ther; 2020 Jul; 19(7):1415-1422. PubMed ID: 32430486
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.
Chen J; Lee H; Schmitt P; Choy CJ; Miller DM; Williams BJ; Bearer EL; Frieboes HB
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1012–1023. PubMed ID: 34524448
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU
Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma.
Jung E; Osswald M; Ratliff M; Dogan H; Xie R; Weil S; Hoffmann DC; Kurz FT; Kessler T; Heiland S; von Deimling A; Sahm F; Wick W; Winkler F
Nat Commun; 2021 Feb; 12(1):1014. PubMed ID: 33579922
[TBL] [Abstract][Full Text] [Related]
14. Glioma cells require one-carbon metabolism to survive glutamine starvation.
Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
Front Immunol; 2019; 10():3137. PubMed ID: 32038644
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
17. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
18. Lipid accumulation and oxidation in glioblastoma multiforme.
Taïb B; Aboussalah AM; Moniruzzaman M; Chen S; Haughey NJ; Kim SF; Ahima RS
Sci Rep; 2019 Dec; 9(1):19593. PubMed ID: 31863022
[TBL] [Abstract][Full Text] [Related]
19. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
[TBL] [Abstract][Full Text] [Related]
20. Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
Prabhu A; Kesarwani P; Kant S; Graham SF; Chinnaiyan P
Neuro Oncol; 2017 Nov; 19(12):1599-1606. PubMed ID: 28541485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
